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Abstract
 
The ability of fungal-derived 
 
 
 
-glucan particles to induce leukocyte activation and the produc-
tion of inflammatory mediators, such as tumor necrosis factor (TNF)-
 
 
 
, is a well characterized
phenomenon. Although efforts have been made to understand how these carbohydrate poly-
mers exert their immunomodulatory effects, the receptors involved in generating these re-
sponses are unknown. Here we show that Dectin-1 mediates the production of TNF-
 
  
 
in re-
sponse to zymosan and live fungal pathogens, an activity that occurs at the cell surface and
requires the cytoplasmic tail and immunoreceptor tyrosine activation motif of Dectin-1 as well
as Toll-like receptor (TLR)-2 and Myd88. This is the first demonstration that the inflamma-
tory response to pathogens requires recognition by a specific receptor in addition to the TLRs.
Furthermore, these studies implicate Dectin-1 in the production of TNF-
 
  
 
in response to
fungi, a critical step required for the successful control of these pathogens.
Key words:
 
 
 
-glucan receptor • macrophages • inﬂammation • tumor necrosis factor • Candida
 
Introduction
 
 
 
-Glucans possess anti-infective and anti-tumorigenic prop-
erties (1–3) that stem from their ability to activate leuko-
cytes, stimulating their phagocytic activity, the production
of reactive oxygen intermediates, inflammatory mediators
and cytokines, including TNF-
 
  
 
(1, 4). The activatory
properties of these fungal-derived carbohydrates, especially
in particles such as zymosan (5), are widely used to examine
the proinflammatory responses of phagocytes. Despite al-
most 50 yr of examination (6), however, the receptor(s)
mediating these effects are still undefined.
We recently identified Dectin-1 (7) as a 
 
 
 
-glucan recep-
tor by screening a RAW264.7 cDNA library with zymosan
(8). Dectin-1 is a small type II transmembrane receptor
containing one lectin-like carbohydrate recognition do-
main, which recognizes 
 
 
 
1,3- and/or 
 
 
 
1,6-linked glucans
and intact yeast (8), and an immunoreceptor tyrosine-based
 
activation motif (ITAM)
 
* 
 
in the cytoplasmic tail (7). In
addition to these exogenous ligands, the receptor can also
recognize an endogenous ligand on T cells (7). The recep-
tor is expressed at high levels on macrophages (M
 
 
 
) and
neutrophils, and to a lesser extent on dendritic cells and a
subpopulation of T cells (9). The human homologue was
found to be structurally and functionally similar to the mu-
rine receptor (10).
We have shown that Dectin-1 acts as a major receptor
for zymosan and other 
 
 
 
-glucans on M
 
  
 
(11) and won-
dered how this receptor contributed to the cellular re-
sponses induced by these carbohydrates. We show here
that Dectin-1 mediates cellular responses to zymosan as
well as to live yeast pathogens. Furthermore, we demon-
strate that this response occurs at the cell surface and re-
quires the cytoplasmic tail of this receptor and the Toll-like
receptor (TLR) pathway. These results are the first evi-
dence that the proinflammatory response requires recogni-
tion by pathogen-specific receptors in addition to the
TLRs, and does not require pathogen internalization.
 
Materials and Methods
 
DNA Constructs.
 
Hemagglutinin (HA)-tagged Dectin-1 was
generated by modifying the 3
 
  
 
end of Dectin-1 cDNA (7, 11) by
PCR to allow the cloning of an adaptor, encoding an HA tag and
a stop codon. The fusion of the HA tag onto the carbohydrate
recognition domain did not affect the ability of this molecule to
recognize zymosan. PCR was used to generate the cytoplasmic
mutant constructs from the full-length HA-tagged Dectin-1, in-
cluding the ITAM mutant where the motif YX
 
11
 
YXXL (amino
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acids 3–18) was mutated to FX
 
11
 
FXXL, and the truncation mu-
tant where the 5
 
  
 
end of the gene encoding the cytoplasmic tail
(amino acids 1–39) was replaced with a start codon (AUG) and
Kozak sequence. All constructs were cloned into the pFB-neo
retroviral vector (Stratagene), packaged into virions using 293T
 
 
 
NX ecotropic cells (provided by G. Nolan, Stanford Univer-
sity, Stanford, CA), and used to transduce RAW264.7 (no. TIB-
71; American Type Culture Collection [ATCC]) M
 
 
 
. Vector-
only transduced cells (RAW-FB) were used as controls. All cell
lines were used as uncloned populations to reduce any founder
effects and were generated and tested at least twice to confirm
their phenotype. V5-tagged TLR-2 was provided by A. Ozinsky
(University of Washington, Seattle, WA; 12).
 
M
 
 
 
.
 
Thioglycollate-elicited peritoneal M
 
  
 
were isolated
from C57BL/6 mice by standard procedures. Animals were kept
and handled according to institutional guidelines. TLR-2
 
 
 
/
 
 
 
,
MyD88
 
 
 
/
 
 
 
, and control bone marrow–derived M
 
  
 
(BMDM;
13, 14) were provided by A. Edwards and C. Reiss e Sousa (Can-
cer Research UK, London, United Kingdom) and T. Kaisho and
S. Akira (Osaka University, Osaka, Japan), respectively. Cells
were maintained in RPMI with 10% heat-inactivated FCS, 50
IU/ml penicillin G, 50 
 
 
 
g/ml streptomycin, and 2 mM
glutamine (RPMI medium), except for the BMDM, which were
cultured in RPMI medium supplemented with 15% (vol/vol) L
cell–conditioned medium as a source of M-CSF (15). Experi-
ments with BMDM were performed in the absence of M-CSF
5–7 d after isolation and culture in L cell–conditioned medium.
Transduced RAW264.7 M
 
  
 
were cultured in RPMI medium
supplemented with 600 
 
 
 
g ml
 
-1 
 
G418 (GIBCO BRL).
 
Fluorescent Zymosan Binding and TNF-
 
  
 
Assays.
 
Cold fluores-
cence-based binding assays using FITC-labeled zymosan (Molec-
ular Probes) were performed as previously described (11). For all
other assays, M
 
  
 
were plated at 2.5 
 
  
 
10
 
5 
 
cells/well in 24-well
plates in RPMI medium the day before each experiment. At the
start of the assay, the cells were cooled to 4
 
 
 
C and washed three
times with prechilled culture medium. When appropriate, glucan
phosphate (GluP; reference 16) was added to 100 
 
 
 
g/ml and the
cells were incubated for 20 min at 4
 
 
 
C to allow inhibition of
Dectin-1 (11). After the addition of FITC-labeled zymosan (20–25
particles/cell) or unlabeled zymosan (100 
 
 
 
g/ml; Sigma-Aldrich),
the cells were incubated at 37
 
 
 
C in 5% CO
 
2 
 
for 30 min unless
stated otherwise. After washes to remove unbound particles, the
cells were then incubated for an additional 3 h at 37
 
 
 
C after
which samples of supernatant were taken for TNF-
 
  
 
measure-
ments. The amount of FITC zymosan bound by the cells was
quantified after lysis with 3% Triton X-100 using a Titretek Flu-
oroskan II (Labsystems Group) as previously described (11).
To obtain opsonized particles, FITC-labeled zymosan was in-
cubated with 20% normal mouse serum in HBSS for 30 min at
37
 
 
 
C and then washed extensively in RPMI medium before use.
Binding assays of the opsonized FITC zymosan were performed
as described above for the unopsonized particles. Similar method-
ology was used to assess the effects of LPS (5 ng/ml; Sigma-
Aldrich) and live yeast particles. For these experiments, 
 
Saccharo-
myces cerevisiae
 
 (BY4741; ATCC no. 201388) and 
 
Candida albicans
 
(ATCC no. 18804) were grown overnight in YPD (CLON-
TECH Laboratories, Inc.) at 30
 
 
 
C, washed extensively in PBS
before use, enumerated, and added to the M
 
  
 
in RPMI medium.
For experiments requiring inhibition of actin polymerization, cy-
tochalasin D in 2 
 
 
 
M DMSO (Sigma-Aldrich) or DMSO alone
was added to the cells 40 min before the start of the assay and
then maintained throughout the experiment. This concentration
of cytochalasin D was sufficient to inhibit zymosan phagocytosis
in RAW M
 
  
 
(unpublished data).
TNF-
 
  
 
was measured using the OptEIA murine TNF-
 
 
 
ELISA kit (BD Biosciences) as described by the manufacturers.
All experiments were repeated in duplicate or triplicate at least
three times. All data are presented as the mean and standard devi-
ation from a representative experiment.
 
Flow Cytometry and Immunofluorescence Microscopy.
 
Flow cy-
tometry was performed according to conventional protocols.
Cells were examined by two-color FACS
 
® 
 
analysis using anti–
Dectin-1 mAb (2A11; reference 11) and phycoerythrin-conju-
gated goat anti–rat IgG (Leinco Technologies). A nonspecific rat
IgG2b was used as an isotype control. For immunofluorescence
microscopy, RAW-Dectin cells were electroporated with the
V5-tagged TLR-2 as previously described (17), plated on acid-
treated glass coverslips, and cultured overnight as described
above. After incubation with zymosan, the cells were fixed, per-
meabilized, and blocked in 5% goat serum and stained with anti-
V5 mAb (Invitrogen) and Cy3 goat anti–mouse IgG (Jackson Im-
munoResearch Laboratories). After a second blocking step in 5%
mouse serum, the cells were stained with Alexaflor 488 anti-HA
(HA11; Covance) to detect Dectin-1. After mounting, the cells
Figure 1. Zymosan-induced TNF-  production is
 -glucan dependent and mediated by Dectin-1. (a)
GluP specifically inhibits the production of TNF-  in
response to unlabeled zymosan in thioglycollate-elic-
ited M . (b) RAW264.7 M  express low levels of en-
dogenous Dectin-1 as measured by FACS® staining us-
ing mAb 2A11. Increased levels of this receptor are
obtained by stably transducing the M   with HA-
tagged Dectin-1, including two cytoplasmic tail mu-
tants. (c) RAW264.7 M   overexpressing Dectin-1
(RAW-Dectin;  ) have an enhanced ability to bind
FITC-labeled zymosan compared with the vector-
transduced control (RAW-FB;  ) and (d) show a
dose-dependent increase in TNF-  production.T
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were observed by confocal laser scanning microscopy (Biorad
1024) on a Nikon Diaphot 200 inverted microscope. Images
were processed using Adobe Photoshop.
 
Results and Discussion
 
The Response to Zymosan Can Be Blocked by Soluble 
 
 
 
-glu-
cans in Primary M
 
 
 
.
 
To explore the possibility that Dec-
tin-1 was involved in mediating the proinflammatory re-
sponses to 
 
 
 
-glucans, we examined the effect of GluP, a
potent soluble 
 
 
 
-glucan inhibitor of Dectin-1 (8), on the
ability of zymosan to induce TNF-
 
  
 
production in primary
M
 
  
 
(Fig. 1 a). The addition of zymosan induced the release
of TNF-
 
  
 
into the M
 
  
 
culture supernatants within 3 h as
previously described (18). However, this response could be
completely inhibited by the addition of GluP and was spe-
cific for zymosan as LPS-induced TNF-
 
  
 
production was
unaffected by the presence of the soluble 
 
 
 
-glucan. The ef-
fect of GluP was consistent with the inhibitory activities
described for other soluble 
 
 
 
-glucans on zymosan-medi-
ated proinflammatory responses (1, 19) and suggested a role
for Dectin-1 in this process.
 
Expression of Dectin-1 in RAW264.7 M
 
  
 
Correlates with
TNF-
 
  
 
Production in Response to Zymosan.
 
To define the
role of Dectin-1, the cellular response to zymosan was ex-
amined using RAW264.7 M
 
 
 
. This M
 
  
 
cell line ex-
pressed low levels of endogenous Dectin-1, allowing us to
examine the effects of zymosan on cells retrovirally trans-
duced to overexpress a HA-tagged version of this receptor
(Fig. 1 b). When compared with control cells (RAW-FB),
increased expression of Dectin-1 (RAW-Dectin) corre-
lated with an increased ability of these cells to bind zymo-
san (Fig. 1 c), as expected (11), but also led to an en-
hanced, dose-dependent TNF-
 
  
 
response in these cells
(Fig. 1 d). As we observed in the primary M
 
 
 
, the en-
hanced TNF-
 
  
 
production could be completely inhibited
by the addition of GluP (see Fig. 4 a and b). Thus, the ex-
pression of Dectin-1 not only correlates with the ability of
these cells to bind zymosan, but also their ability to pro-
duce TNF-
 
  
 
in response to these particles.
 
Dectin-1 Mediates the Production of TNF-
 
  
 
in Response to
Live Yeast Pathogens.
 
As Dectin-1 can recognize intact
yeast particles (8), and as TNF-
 
  
 
is an essential cytokine re-
quired for the successful control of many fungal pathogens
(20–23), we examined the possibility that this receptor
could also mediate a proinflammatory response to live or-
ganisms (Fig. 2). When live 
 
C. albicans
 
 (Fig. 2 a) and 
 
S. cer-
evisiae
 
 (Fig. 2 b) were added to the M
 
 
 
, they induced en-
hanced levels of TNF-
 
  
 
in RAW-Dectin M
 
  
 
compared
with the control (RAW-FB) cells. Significantly, these re-
sponses could be inhibited by the addition of GluP. Thus,
this is the first description of a receptor involved in gener-
Figure 2. Dectin-1 induces the production of TNF-  in response to
live yeasts. RAW-Dectin M   display an enhanced ability to induce
TNF-  in response to live (a) C. albicans and (b) S. cerevisiae. Live yeasts
were added at a multiplicity of infection of 5:1. Note that the response to
S. cerevisiae is significantly greater than to C. albicans and that these re-
sponses are  -glucan dependent.
Figure 3. TLRs are required for TNF-  production in response to zy-
mosan. (a) BMDM from TLR-2– or MyD88-deficient mice do not pro-
duce TNF-  after overnight incubation with unlabeled zymosan. The re-
sponse to overnight incubation with 5 ng/ml LPS is shown as a control.
(b–e) V5-Tagged TLR-2 (red) and HA-tagged Dectin-1 (green) colocal-
ize within 5 min after the addition of zymosan. (b) Light micrograph
showing RAW-Dectin cells binding zymosan. Anti-HA (c) and anti-V5
(d) staining showing colocalization (e) of Dectin-1 and TLR-2, respec-
tively, at the zymosan phagocytic cup. The cell indicated with an arrow
was not transfected with V5-tagged TLR-2 and is presented as a staining
control. Colocalization of these receptors at the cell surface in contact
with zymosan were also observed after 30-min incubation at 37 C with
Cytochalasin D (unpublished data).T
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ating a proinflammatory response to fungal pathogens and
it suggests that Dectin-1 may have an important role in the
innate response to these organisms.
 -Glucan is traditionally thought to be buried within the
fungal cell wall (24), but the ability of Dectin-1 to recog-
nize these organisms implies that  -glucan is present on the
yeast cell surface. In addition, S. cerevisiae induced far
greater levels of TNF-  than C. albicans (Fig. 2) and were
also bound more efficiently to the M  (unpublished data),
indicating differences in the amount of exposed  -glucan
in these yeasts. This difference and the ability of other
pathogens, such as Paracoccidioides brasiliensis (25), to modify
their cell wall  -glucan content during infection is sugges-
tive that fungal pathogens may mask their cell wall  -glu-
can to avoid immune recognition through Dectin-1.
The TLR Pathway Is Also Required to Trigger the Proinflam-
matory Response to Zymosan. TLRs are thought to sample
the phagosomal contents, triggering a response appropriate
to the pathogen, and have been shown to be involved in
the recognition of fungal pathogens (26), zymosan (27),
and other  -glucans (28). Indeed, BMDM from MyD88
and TLR-2 knockout mice were unable to induce TNF- 
production in response to zymosan (Fig. 3 a), despite be-
ing capable of binding and internalizing this particle (un-
published data). We also observed colocalization of TLR-2
and Dectin-1 in membrane areas in contact with zymosan
in RAW-Dectin M  (Fig. 3 b–e). These results, in con-
junction with the data presented in Fig. 1, indicated that
the enhanced  -glucan–dependent TNF-  response ob-
served in the transduced RAW264.7 M  may have been a
result of increased, Dectin-1–mediated zymosan availabil-
ity to which the TLRs were subsequently recognizing and
responding.
To investigate this hypothesis, we used complement op-
sonized zymosan for Dectin-1–independent delivery of zy-
mosan to the M  cell surface and examined the TNF-  re-
sponse in the presence or absence of GluP (Fig. 4).
Opsonized zymosan is recognized by both Dectin-1 and
CR3 (11), the latter of which is expressed at equivalent
levels in RAW-FB and RAW-Dectin M  (unpublished
data). Although complement opsonization led to greatly in-
creased levels of zymosan binding in RAW-FB M  (Fig. 4
a) as expected, the levels of TNF-  were only marginally
increased and were no longer  -glucan dependent (Fig. 4
b). M  overexpressing Dectin-1, however, still possessed
an enhanced  -glucan–dependent TNF-  response to op-
sonized zymosan. Thus, these data suggested that it was not
the increased availability of zymosan that was leading to the
enhanced,  -glucan–dependent production of TNF- , but
was rather a direct result of the higher levels of Dectin-1
expressed in these cells.
As Dectin-1 appeared to contribute to the TNF-  re-
sponse to zymosan, we next looked at the possibility that
the cytoplasmic tail of this receptor was involved in this
Figure 4. The  -glucan–dependent TNF-  response to zymosan is
mediated by Dectin-1. Although opsonization increases the amount of
FITC-labeled zymosan bound by RAW-FB M  (a), TNF-  production
is only marginally increased and is no longer  -glucan dependent (b). In
contrast, M  overexpressing Dectin-1 (RAW-Dectin) still possess an en-
hanced  -glucan–dependent response to opsonized zymosan.
Figure 5. The cytoplasmic tail of Dectin-1 is in-
volved in mediating the TNF-  response to zymosan.
The cell lines expressing the Dectin-1 cytoplasmic tail
mutants display an enhanced ability to bind FITC-
labeled zymosan (a), but they do not transduce an in-
tracellular signal inducing the TNF-  response to this
particle (b). This effect is not due to lack of internaliza-
tion of the zymosan as signaling still occurs, and is even
enhanced, when phagocytosis is inhibited with cyto-
chalasin D (c; cytoD).T
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process. For this analysis we generated RAW264.7 cell
lines expressing mutant forms of Dectin-1, including a cell
line expressing receptors lacking a functional ITAM motif
(RAW-ITAM) as well as a cell line expressing a truncated
receptor lacking the entire cytoplasmic tail (RAW-Trunca-
tion). Both cell lines expressed the mutated forms of Dec-
tin-1 at the cell surface (Fig. 1 b) and mediated enhanced
 -glucan–dependent zymosan binding to these cells, com-
parable to that obtained with the wild-type receptor (Fig. 5
a). In contrast, however, M  expressing the mutated re-
ceptors did not show elevated levels of TNF-  in response
to zymosan (Fig. 5 b).
Because the cytoplasmic tail and ITAM motif of Dec-
tin-1 are required for phagocytosis of zymosan (unpublished
data and reference 8), it was possible that the failure to in-
duce TNF-  was due to the lack of particle internalization.
We explored this possibility by inhibiting zymosan phago-
cytosis using cytochalasin D (29) and measuring the effects
on TNF-  production (Fig. 5 c). Although the ability of
these M  to bind zymosan was unaffected by the presence
of cytochalasin D (unpublished data), greatly elevated levels
of  -glucan–dependent TNF-  were obtained in both the
control (RAW-FB) and RAW-Dectin cells. Furthermore,
colocalization of TLR-2 and Dectin-1 with zymosan at the
cell surface was still observed after cytochalasin D treatment
(unpublished data). Thus, these data suggest that the TNF- 
response to zymosan does not require particle internaliza-
tion but does require the cytoplasmic tail of Dectin-1.
Overall, our data suggest that Dectin-1 is a key receptor
involved in mediating the biological effects of  -glucans.
Furthermore, through its ability to recognize these carbo-
hydrates, Dectin-1 is likely to be centrally involved in the
innate response to fungal pathogens. We have also shown
that pathogen-specific receptors, in addition to the TLR
receptors, are required to generate proinflammatory re-
sponses to pathogens. Given the multitude of non-TLR re-
ceptors involved in pathogen recognition, future studies
will undoubtedly show that this is a common paradigm in
innate immunity.
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